Home/Pipeline/BRCA1/2 Testing

BRCA1/2 Testing

Breast and Ovarian Cancer Risk

CommercialActive

Key Facts

Indication
Breast and Ovarian Cancer Risk
Phase
Commercial
Status
Active
Company

About DeltaGene

DeltaGene is a private, revenue-generating diagnostics company based in Budapest, Hungary. Its core business is providing direct-to-consumer and clinical genetic testing services, primarily focused on hereditary cancer panels (e.g., BRCA1/2), comprehensive genetic screenings, and supporting targeted cancer therapy decisions. The company leverages its in-house NGS capabilities to offer a range of diagnostic packages, positioning itself in the growing market for preventive and personalized genetic healthcare in Hungary and the surrounding region.

View full company profile

Therapeutic Areas